Asthma | Diseases of the Lung, Phase IIA
Tezepelumab COPD Exacerbation Study (COURSE)
Volunteers
Health Professionals
What is the purpose of this trial?
To evaluate the effect of tezepelumab as compared with placebo on COPD exacerbations in subjects with moderate to very severe COPD
- Trial withAstraZeneca Pharmaceutical LP
- Ages40 years - 80 years
- GenderBoth
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Last Updated07/18/2023
- Study HIC#2000026323